Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Aderka

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Cancer|June 1, 1988
Recombinant interferon alpha-C for advanced hairy cell leukemia. An Israeli multicenter studyD Aderka, R Michalevicz, Y Daniel, et al.
Cytokine|May 1, 1993
Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cellsA P Cope, D L Gibbons, D Aderka, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1995
Systemic leakage and side effects of tumor necrosis factor alpha administered via isolated limb perfusion can be manipulated by flow rate adjustmentP Sorkin, S Abu-Abid, D Lev, et al.
Arthritis and Rheumatism|August 1, 1993
Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosusD Aderka, A Wysenbeek, H Engelmann, et al.
Arthritis and Rheumatism|October 1, 1992
Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseasesA P Cope, D Aderka, M Doherty, et al.
British Journal of Cancer|July 30, 2014
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriersT Golan, Z S Kanji, R Epelbaum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2019
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trialS Stintzing, P Wirapati, H-J Lenz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2012
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision makingH J Schmoll, E Van Cutsem, A Stein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2016
ESMO consensus guidelines for the management of patients with metastatic colorectal cancerE Van Cutsem, A Cervantes, R Adam, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Cancer|June 1, 1988
Recombinant interferon alpha-C for advanced hairy cell leukemia. An Israeli multicenter studyD Aderka, R Michalevicz, Y Daniel, et al.
Cytokine|May 1, 1993
Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cellsA P Cope, D L Gibbons, D Aderka, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1995
Systemic leakage and side effects of tumor necrosis factor alpha administered via isolated limb perfusion can be manipulated by flow rate adjustmentP Sorkin, S Abu-Abid, D Lev, et al.
Arthritis and Rheumatism|August 1, 1993
Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosusD Aderka, A Wysenbeek, H Engelmann, et al.
Arthritis and Rheumatism|October 1, 1992
Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseasesA P Cope, D Aderka, M Doherty, et al.
British Journal of Cancer|July 30, 2014
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriersT Golan, Z S Kanji, R Epelbaum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2019
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trialS Stintzing, P Wirapati, H-J Lenz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2012
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision makingH J Schmoll, E Van Cutsem, A Stein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2016
ESMO consensus guidelines for the management of patients with metastatic colorectal cancerE Van Cutsem, A Cervantes, R Adam, et al.
Pageof 13